Login / Signup

Investigation of topical intranasal cocaine for sinonasal procedures: a randomized, phase III clinical trial.

John McGrathAlexa McGrathJacob BurdettTom ShokriJason E Cohn
Published in: International forum of allergy & rhinology (2020)
Topical 4% and 8% cocaine is an effective anesthetic that can be safely administered for nasal procedures.
Keyphrases
  • phase iii
  • clinical trial
  • open label
  • phase ii
  • double blind
  • chronic rhinosinusitis
  • wound healing
  • placebo controlled
  • prefrontal cortex
  • study protocol
  • randomized controlled trial